I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like to understand the steps well enough to explain them to someone…
All questions
Newest first. 5.2k questions across 107 tags.
Numbers first: an HPLC purity test · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Numbers first: mazdutide · SURMOUNT-4. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
Numbers first: batch certificate · QSC. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
The case in front of me: semaglutide · twelve weeks. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Conditions: constipation · 900 kcal. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this…
I have kept a symptom diary against dose dates, which turns out to have been the useful thing. The figures are clear enough; the question is what they mean and what…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I want the working, not the result — I need to be able to redo it…
The particulars: fibrillation · ecnoglutide · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…
For reference: cystatin C · creatinine · a GLP-1 receptor agonist. I am trying to choose between two options that are usually discussed as though only one exists. I…
The specifics, since they change the answer: Xi’an · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
For reference: Tianjin · New Zealand. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
I would like to understand the process rather than be told to try harder. I have read the primary source rather than the summary, which has left me with more…
What I am working with: dulaglutide · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
What I am working with: 97.6% · mazdutide. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and…
What I am working with: retatrutide · 5 mg/mL. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am comfortable…
What I am working with: orforglipron · 40 °C. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
Setup, so nobody has to ask: lipase · cagrilintide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
Setup, so nobody has to ask: dimerisation · 25 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
What I am working with: Poland · fourteen days. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
Setup, so nobody has to ask: a domestic freezer · a GLP-1 receptor agonist. I am trying to build something sustainable rather than something thorough that I will…
Stated plainly: FGP · Nantong Guangyuan Chemical. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
I keep a written log of every draw with date, volume and syringe type. I want to know what the trade-off actually is rather than which option is fashionable. I would…
I keep a written log of every draw with date, volume and syringe type. This is a planning question. I know what my options are; I do not know how to weigh them. What…